A combined approach with whole genome sequencing and artificial intelligence, towards combating antimicrobial resistance in tuberculosis, by generating a comprehensive drug susceptibility report for individual patients, a 100X faster than existing solutions.
Benefits
There is a dearth of tools in the market that can provide a rapid and comprehensive diagnosis of drug-resistant tuberculosis. Hence, AarogyaAI®’s algorithm is extremely relevant as it provides a comprehensive precision drug susceptibility report for the patients, based on the genome of the M. tb infecting the patient.
AarogyaAI Innovations Private Limited:, Bangalore, Karnataka
Accessibility Controls